Published in
Elsevier, Annals of Oncology, 2(32), p. 208-217, 2021
DOI: 10.1016/j.annonc.2020.11.011
Links
Tools
Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer: Final Overall Survival Results From SOLAR-1
Journal article published in 2020 by
F. André 
,
E. M. Ciruelos,
D. Juric,
S. Loibl,
M. Campone,
I. A. Mayer,
G. Rubovszky,
T. Yamashita,
B. Kaufman,
Y.-S. Lu ,
K. Inoue,
Z. Pápai,
M. Takahashi,
F. Ghaznawi,
D. Mills
and other authors.
,
E. M. Ciruelos,
D. Juric,
S. Loibl,
M. Campone,
I. A. Mayer,
G. Rubovszky,
T. Yamashita,
B. Kaufman,
Y.-S. Lu ,
K. Inoue,
Z. Pápai,
M. Takahashi,
F. Ghaznawi,
D. Mills
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 